Regina
Meade§, Donna Picard¶, Kathy Singleton, Dorothy
Smith#,
M. Blake Caldwell**, Alfred DeMaria*, Ho-Wen
Hsu*, the
Massachusetts Working Group on Surveillance of HIV in Children,
Massachusetts Department of Public
Health,
and the Centers for Disease Control and Prevention
From the * Massachusetts Department of Public
Health, Jamaica Plain, Massachusetts; the Children's Hospital, Boston,
Massachusetts; the § Boston City Hospital, Boston, Massachusetts; the ¶
Greater Lawrence Family Health Center, Lawrence, Massachusetts; the
Baystate Medical Center, Springfield, Massachusetts; the # University of
Massachusetts Medical Center, Worcester, Massachusetts; and the **
Division of HIV/AIDS Prevention, Centers for Disease Control and
Prevention, Atlanta, Georgia.
Objective. Many children with human
immunodeficiency virus (HIV) infection are surviving long enough to
reach school age. This study describes issues related to school
attendance and disclosure of HIV infection in a population of
HIV-infected children.
Methods. A statewide pediatric HIV surveillance
system was used to collect data on school-age (5 years old) HIV-infected
children. In addition, HIV clinic nurses familiar with the child's
history participated in a cross-sectional survey that collected
information on school-related issues during the 1993-1994 school year.
Results. Of the 92 school-age children, only 3
were too ill to attend school. Another 5 children were home-schooled. Of
the 84 who attended school outside the home, 25% had severe symptoms of
HIV infection (Centers for Disease Control and Prevention [CDC] clinical
category C). Absence from school ranged from less than 2 weeks during
the year for half of the children (51%) to more than 8 weeks for 9
children (12%). Twenty-nine percent of the children received medication
in school, usually administered by the school nurse. Over two thirds of
the 50 children ages 5 to 10 years had not been told that they had HIV
infection. Only 1 of the 20 children more than 10 years of age was not
aware of her HIV infection. For 53% of the children attending school, no
school personnel had been informed of the child's HIV infection.
Administration of HIV medications at school, age of child, and treatment
at one particular HIV clinic were associated with the parents' decision
to inform school personnel. In the 47% of cases where the school had
been informed, school nurses were most frequently notified, followed by
principals and teachers.
Conclusion. Only 3% of school-age children were
too ill to attend school, and almost all were enrolled in public
schools. The number of HIV-infected children reaching school age will
continue to grow, and public schools will bear the responsibility for
educating these children. Health care providers will increasingly be
called upon for guidance by both educators and families to assure that
HIV-infected children receive the best education possible.
Key words: HIV, AIDS, school issues,
confidentiality.
This article has been cited by other articles:
Thomas, M., Bedford-Russell, A., Sharland, M.
(2000). Hospitalisation for RSV infection in ex-preterm
infants---implications for use of RSV immune globulin. Arch. Dis. Child.
83: 122-127 [Abstract] [Full Text]
Hediger, M. L, Overpeck, M. D, Ruan, W J.,
Troendle, J. F (2000). Early infant feeding and growth status of US-born
infants and children aged 4-71 mo: analyses from the third National
Health and Nutrition Examination Survey,1988-1994. Am. J. Clin. Nutr.
72: 159-167 [Abstract] [Full Text]
Regina
Meade§, Donna Picard¶, Kathy Singleton, Dorothy
Smith#,
M. Blake Caldwell**, Alfred DeMaria*, Ho-Wen
Hsu*, the
Massachusetts Working Group on Surveillance
of HIV in
Children, Massachusetts Department of Public
Health,
and the Centers for Disease Control and
Prevention
From the
* Massachusetts Department of Public Health, Jamaica Plain,
Massachusetts; the Children's Hospital, Boston,
Massachusetts; the § Boston City Hospital, Boston, Massachusetts; the ¶
Greater Lawrence Family Health Center, Lawrence,
Massachusetts; the Baystate Medical Center, Springfield, Massachusetts;
the # University of Massachusetts Medical Center,
Worcester, Massachusetts; and the ** Division of HIV/AIDS Prevention,
Centers for Disease Control and Prevention, Atlanta,
Georgia.
ABSTRACT
Objective. Many children with human
immunodeficiency virus (HIV) infection are surviving long enough to
reach school age. This study describes issues related to school
attendance and disclosure of HIV infection in a population of
HIV-infected children.
Methods. A statewide pediatric HIV
surveillance system was used to collect data on school-age (5 years old)
HIV-infected children. In addition, HIV clinic nurses familiar with the
child's history participated in a cross-sectional survey that collected
information on school-related issues during the 1993-1994 school year.
Results. Of the 92 school-age children,
only 3 were too ill to attend school. Another 5 children were
home-schooled. Of the 84 who attended school outside the home, 25% had
severe symptoms of HIV infection (Centers for Disease Control and
Prevention [CDC] clinical category C). Absence from school ranged from
less than 2 weeks during the year for half of the children (51%) to more
than 8 weeks for 9 children (12%). Twenty-nine percent of the children
received medication in school, usually administered by the school nurse.
Over two thirds of the 50 children ages 5 to 10 years had not been told
that they had HIV infection. Only 1 of the 20 children more than 10
years of age was not aware of her HIV infection. For 53% of the children
attending school, no school personnel had been informed of the child's
HIV infection. Administration of HIV medications at school, age of
child, and treatment at one particular HIV clinic were associated with
the parents' decision to inform school personnel. In the 47% of cases
where the school had been informed, school nurses were most frequently
notified, followed by principals and teachers.
Conclusion. Only 3% of school-age children
were too ill to attend school, and almost all were enrolled in public
schools. The number of HIV-infected children reaching school age will
continue to grow, and public schools will bear the responsibility for
educating these children. Health care providers will increasingly be
called upon for guidance by both educators and families to assure that
HIV-infected children receive the best education possible.
Key words: HIV, AIDS, school issues,
confidentiality.
INTRODUCTION
Children with human immunodeficiency virus (HIV)
infection have been attending our nation's schools in increasing numbers
for over a decade. The estimated number of HIV-infected children living
in the United States in early 1994 was 12 240, and 39% (4820) of those
children were age 5 or older.1 An estimated 1630 HIV-infected children
were born in 1993 alone and these children have a median life expectancy
of 9.4 years2; thus, many more HIV-infected children can be expected to
enter and remain in school in years to come. As more children with HIV
infection survive long enough to enter school, families and schools are
faced with a number of complex medical and social issues.3 These issues
include the impact of illness on school attendance, disclosure of HIV
infection status, confidentiality surrounding disclosure, and medication
use during school hours.
In the early years of the acquired immunodeficiency
syndrome (AIDS) epidemic in this country, children identified with HIV
infection were sometimes forced to leave their schools.7 In August 1985,
the Centers for Disease Control and Prevention (CDC) first released
guidelines regarding school placement of HIV-infected children.8 In
March 1986, the American Academy of Pediatrics (AAP) issued similar
guidelines,9 encouraging school attendance for most children with HIV
infection. In some areas of the country, school system policies require
that schools be informed about the attendance of an HIV-infected
child.10 The Massachusetts policy, in keeping with state law regarding
the confidentiality of medical information, leaves the decision to
inform school personnel of a child's HIV infection to the parents or
guardians of each child.11
Although increasing numbers of school-age children
with HIV infection are attending school, little has been written about
their experiences. Previous studies of school-related issues among
HIV-infected children have addressed placement in public schools;12
academic, behavioral, and psychological issues of HIV-infected children
with hemophilia;13,14 prenatal drug exposure;5 and special service
needs.6 We undertook this survey to describe the experiences of children
with HIV infection in schools across Massachusetts. We examined whether
the children had been told about their HIV infection status and whether
schools knew of their infection. We also describe school absences due to
HIV-related illnesses.
METHODS
The Pediatric Spectrum of Disease (PSD) study is a
multicenter active surveillance study of pediatric HIV infection
coordinated by the CDC. In Massachusetts, the PSD study is based at the
State Public Health Department. Data collection began in 1989 and all
children born after January 1, 1977 who were known to be HIV-infected or
were born to HIV-infected mothers were eligible for inclusion.
Children were identified through HIV clinics at
each hospital site. Study nurses at each site abstracted all available
medical records at initial enrollment and provided updates at 6-month
intervals. The information collected on each child included demographic
and social characteristics, mode of HIV exposure, clinical symptoms,
HIV-related treatment, and laboratory data. Patient confidentiality was
protected by identifying children only through an alphanumeric code.
Data forms containing only the patient codes were sent to the PSD study for data
entry. Data were collected at seven medical centers that included all
pediatric HIV clinics in the state. Yearly surveys of all pediatric care
providers in the state were performed to validate that virtually all
known HIV-infected children were seen at these medical centers.
The study population consisted of HIV-infected
children enrolled in the PSD study who were born before 1989 and were
still alive and being monitored in 1993. In addition to demographic and
clinical information routinely collected by the PSD study, specific
information about the 1993-1994 school year including each child's type
of school and grade, absences, medications, and whether the child and
school were told about the child's HIV infection was collected on
standard forms after the end of the school year. This information was
obtained by PSD study nurses who also provided HIV care to the children
and were informed about school issues by parents. Data on clinical stage
of disease and laboratory values reflected the child's status asof
January 1994.
Differences between categorical variables were
compared by the 2 test. Logistic regression was performed using SAS (SAS
Institute, Inc, Cary, NC) version 6.08.
RESULTS
Patient Population
Of the 100 eligible children, 97 had surveys
completed by nurses at the five clinics where these children receive
medical care. Of these, 5 children born in 1988 had not yet started
kindergarten in 1993 and were excluded from the analysis. (One clinic
caring for only 2 school-aged children was grouped with another nearby
clinic.) Demographic characteristics for the 92 school-age children are
shown in Table 1. The overall mean age of the children was 8.5 years
(median 8, range 5 to 17).
The mean age of the 77 children with perinatally
acquired infection was 7.5 years (median 7, range 5 to 15), compared
with a mean age of 13 years (median 13, range 10 to 17) for the 15
children with hemophilia-related or transfusion-acquired infection.
Thirty-nine percent of the children were black, 33% were white, and 28%
were Hispanic; 54% were male and 46% were female. More than half of the
children (58%) lived with a biological parent, and most (83%) attended
public school. Eight children were excluded from analysis of
school-related issues because they either received home-based schooling
(n = 5) or were considered by their parents to be too ill to attend
school (n = 3).
Clinical Status
Fig 1 shows the CDC clinical stage of illness15 for
children attending school during the 1993-1994 school year. Twenty-five
percent had severe symptoms of HIV infection (category C), 55% had
moderate symptoms (category B), and only 20% had mild or no symptoms
(category N or A). Twenty-nine percent of the children had CD4
T-lymphocyte counts of 200 or less, 34% between 201 and 500, and 38%
over 500. Thirty-three (39%) of the children had been diagnosed with at
least one AIDS-defining condition. Four children attending school had
gastrostomy tubes for nutritional supplementation. Three (4%) of the
children attending school died during the school year.
School-related Issues
Table 2 shows school-related information for the 84
children who attended school outside the home. Most of the children were
in elementary school (grades kindergarten through 5). Six percent of the
children received some tutoring during the school year. Ninety-seven
percent of the children were taking antiretroviral medication; however,
only 29% of the children received medications while in school (Table 2).
Of these, 74% had their medication administered by the school nurse. All
children who self-administered their medication were in grade 8 or
above.
Forty-nine percent of children missed 2 or more
weeks of school, and 12% missed more than 8 weeks. Five children had
absences related to nonmedical issues as well as HIV: 3 missed school
because of their mother's illness, and 2 because of social issues not
related to HIV. Of the children with mild symptoms, 75% were absent for
less than 2 weeks, compared with 51% of children with moderate symptoms
and 27% of children with severe symptoms (P < .01). Twenty-three
children (27%) were hospitalized a total of 44 times during the school
year (September through June) with a range of 1 to 5 hospitalizations
per child. The mean number of hospital days per child was 5.5.
Seventy-four percent of the hospitalizations were for stays of 1 week or
less.
Disclosure of HIV Infection to the Child and School
Thirty-seven children (42%) had been told that they
had HIV infection. The average age at disclosure was 8 years. Fig 2
shows the proportions who had been told of their HIV infection by age.
Over two-thirds of children ages 5 through 10 years had not been told
that they had HIV infection, whereas only 1 of the 20 children over age
10 years did not know, a 14-year-old girl who was described as being
cognitively limited. Clinical severity of the child's symptoms was not
associated with whether or not the child was told of his/her disease
status. Forty-eight percent of children with severe symptoms had been
told compared with 39% of children with mild to moderate symptoms. There
was also no difference between children living with biological parents
(39% informed) and children living with other primary caregivers (45%
informed). Among the children who had been told, initial disclosure was
most often done by family members alone (59%), by a family member
together with medical staff (24%), or by medical staff alone (16%) at
the request of the family.
Forty-seven percent of the families had informed
someone in the school of their child's HIV infection. In 26% of cases
where the school was informed, medical and/or social service staff from
the HIV clinic had assisted the family in informing and educating school
personnel. Although more than one school official was frequently
informed, the decision regarding who to inform was made by the family.
School nurses, principals, and classroom teachers, in that order, were
the most likely to be informed by families (88%, 62%, and 47%,
respectively).
We next examined whether any demographic or
clinical factors were associated with families choosing to inform the
school about their child's HIV infection. Schools were more likely to be
informed about children who were 9 years old, took medication at school,
and were cared for at clinic C (Table 3). In a multiple logistic
regression model, only medication taken during school and treatment at
HIV clinic C remained independently associated with informing school
personnel. Ninety-one percent of the children at clinic C had informed
someone in their school, compared with 15% to 51% at the other clinic
sites. In addition, 64% of children seen at clinic C knew their HIV
status, compared with 20% to 40% of children at other sites.
For some of the children in our study, only the
school or the child (but not both) knew of the child's HIV infection.
Thirteen children (18%) had not been told that they were infected, but
school personnel had been informed. Conversely, 10 children (14%) knew
they were infected, but their families had not informed the school.
DISCUSSION
This study of a population-based sample of
school-age children focuses on disclosure of the child's HIV status to
the child and to school personnel. One of the most difficult issues for
parents is deciding when and how to tell HIV-infected children about
their diagnosis. We found that by age 10, over half of our children had
been informed, similar to the findings of Grubman et al16 in their
cohort of older children. Our study also included younger school-age
children, most of whom had not been told that they were HIV-infected.
Although young children with cancer are now commonly told their
diagnosis when treatment for their disease is begun, the social issues
surrounding a diagnosis of HIV infection make disclosure a much more
complex issue.17
Disclosure may often be contemplated by parents or
guardians, but many feel unprepared to face the sensitive questions that
may arise following disclosure. Many children already know or suspect
their diagnosis even if no one has actually discussed it with them.18
Parents often turn to medical personnel for guidance and support on this
issue. In over one third of our families whose children had been told
that they had HIV infection, a member of the health care team had been
present when the child was first informed. Although the questions of
when and how best to inform a child remain unanswered, there is general
agreement that children of normal cognitive development can benefit from
the opportunity to openly discuss their illness with adults whom they
trust.19
The decision to inform school personnel of a
child's HIV infection is associated with tremendous anxiety for the
family, who needs to weigh the potential benefits of disclosure with the
fear of discrimination or loss of privacy. Several families were
influenced by publicized reports of how their school system or community
had responded to previous disclosures about HIV-infected students.
Because medical management of this disease plays such a large part in an
HIV-infected child's life,
confidentiality becomes increasingly difficult to
maintain as the disease progresses. The administration of medications in
school was a strong predictor of whether the school was informed of the
diagnosis. Families who choose not to inform the school may have to
arrange complex medication schedules to avoid administration during
school hours. One older child in our study took his medication in the
school bathroom to avoid having to inform the school nurse.
The other key predictor of whether families chose
to inform the school was treatment at a particular HIV clinic, possibly
indicating the influence of medical personnel on the family's decision.
Wiener and Septimus20 have outlined the many ways in which the health
care team can be helpful to families in their interactions with the
school system. The staff at HIV clinic C actively encourages families to
inform the school, often accompanying the parents to meetings with
school personnel. Support from health care providers may increase the
family's ability to talk openly about their child's illness. Close
communication between the health care team and school personnel can also
help to address concerns the school may have about the care of these
children. All of our HIV clinics reported that the continued contact
they had with the schools revolved around medical issues, including
immunizations, medications, absences, illnesses, and participation in
school activities.
The difficulty of maintaining confidentiality when
the family had not disclosed the child's HIV status to the school was a
recurrent theme reported by many of the HIV clinic nurses. Children may
be faced with questions from school personnel and classmates because of
repeated absences and hospitalization. School personnel may suspect or
assume the diagnoses even if they have not been officially informed.
When a child whose HIV infection was not known to the school had medical
problems that necessitated communication between the school and the
clinic, medical personnel were required to avoid specific mention of
HIV. A child's schooling can also be disrupted when a family does not
feel comfortable about informing the school of the child's infection.
One family removed their child from a school because the teacher
questioned the child about his illness. Neither the child nor the school
knew of the HIV diagnosis at that time.
A major limitation of our study was that we
received information from HIV clinic nurses instead of from direct
interviews of the parents, children, or school officials. We also were
unable to compare children's school absences and grade performance with
those of uninfected children living in similar environments. Further
research is needed to study the complex social support needs of the
HIV-infected child as well as the support that school personnel may need
when a student is identified as HIV-infected. A better understanding of the impact
of the illness and death of HIV-infected children on their classmates is
also of interest.
The findings that only 3% of school-age
HIV-infected children were too ill to attend school and that most were
enrolled in public schools indicates that public school systems are
bearing the major responsibility for educating HIV-infected children. A
recent survey of the largest school districts in the country shows that
school systems have in fact begun to formulate policies that respect the
privacy of the family while not compromising the child's education.21,22
Although the decision to inform the school about a
child's HIV infection rests with the family in most cases, the health
care team can be instrumental in assisting the family in making their
decision and serving as an advocate for the child in the educational
system. Health care providers should offer guidance to school personnel
regarding the medical issues that may arise for the HIV-infected child
while under their supervision. Communication between health care
providers and school personnel is essential for meeting both the medical
and educational needs of the HIV-infected child.
FOOTNOTES
Received
for publication Nov 7, 1996; accepted Jan 22, 1997.
Reprint
requests to (J.C.) Massachusetts Department of Public Health, State Lab
Institute, 305 South Street-5th Floor,
Jamaica
Plain, MA 02130.
ACKNOWLEDGMENTS
This
research was supported by contract U64/CCU101187 from the Division of
HIV/AIDS at the US Centers for Disease
Control
and Prevention.
We thank
Jeanne Bertolli for her support and helpful discussion.
Members
of the Massachusetts Working Group on Surveillance of HIV in Children:
Baystate Medical Center, Barbara
Stechenberg, MD; Boston Children's Hospital, Kenneth McIntosh, MD;
Boston City Hospital, Stephen Pelton, MD;
Massachusetts Department of Social Services, Suzanne Tobin, RN;
Massachusetts General Hospital, Mark Pasternack, MD;
New
England Medical Center, Cody Meissner, MD; and University of
Massachusetts Medical Center, John Sullivan, MD.
ABBREVIATIONS
HIV, human immunodeficiency virus. AIDS, acquired
immunodeficiency virus. CDC, Centers for Disease Control and Prevention.
AAP, American Academy of Pediatrics. PSD, Pediatric Spectrum of Disease
(study).
REFERENCES
1. Davis SF, Byers RH, Lindegren ML, Prevalence and incidence of
vertically acquired HIV infection in the United States JAMA. 1995;
274:952-955[Medline].
2. Barnhart HX, Caldwell MB, Thomas P, Natural history of
human immunodificiency virus disease in perinatally infected children:
an analysis from the Pediatric Spectrum of Disease project. Pediatrics.
1996; 97:710-716[Abstract]
3. Crocker AC, Lavin AT, Palfrey JS, Supports for children
with HIV infection in school: best practices guidelines. J Sch Health.
1994; 64:32-38[Medline]
4. Katz DL. Legal issues relevant to HIV-infected children in home,
day care, school, and community. In: Pizzo PA, Wilfert CM, eds.
Pediatric AIDS: The Challenge of HIV Infection in Infants, Children and
Adolescents. 2nd ed. Baltimore, MD: Williams & Wilkins: 1994:907-922
5. Havens JF, Whitaker AH, Feldman JF, Ehrhardt AA Psychiatric
morbidity in school-age children with congenital human immunodeficiency
virus infection: a pilot study. J Dev Behav Pediatr. 1994;
15:S18-S25[Medline
6. Papola P, Alvarex M, Cohen HJ Developmental and service needs of
school-age children with human immunodeficiency virus infection: a
descriptive study. Pediatrics. 1994; 94:914-918[Abstract]
7. National Association of State Boards of Education. Someone
At School Has AIDS. The Complete Guide to Education Policies Concerning
HIV Infection. Draft, 1995
8. Centers for Disease Control and Prevention Guidelines for
education and foster care of children infected with human T-lymphotropic
virus type III/lymphadenopathy-associated virus. MMWR. 1985; 34:517-520
9. American Academy of Pediatrics, Committee on School Health
and Committee on Infectious Diseases School attendance of children and
adolescents with human T-lymphotropic virus III/lymphadenopathy-associated
virus infection Pediatrics. 1986; 77:430-432[Medline]
10. Harvey DC Confidentiality and public policy regarding children
with HIV infection. J Sch Health. 1994; 64:18-20[Medline]
11. Massachusetts Department of Public Health, Massachusetts
Department of Education. Updated Medical Policy Guidelines. Children and
Adolescents with AIDS/HIV Infection in School Settings. Boston, MA:
Massachusetts Department of Public Health, Massachusetts Department of
Education; May 1993
12. Santelli JS, Birn A-E, Linde J School placement for human
immunodeficiency virus-infected children: the Baltimore city experience.
Pediatrics. 1992; 89:843-848[Abstract]
13 Colgrove RW, Huntzinger RM Academic, behavioral, and
social adaptation of boys with hemophilia/HIV disease. J Pediatr Psychol.
1994; 19:457-473[Abstract]
14. Whitt JK, Hooper SR, Tennison MB, Neuropsychologic functioning
of human immunodeficiency virus-infected children with hemophilia. J
Pediatr. 1993; 122:52-59[Medline]
15. Centers for Disease Control and Prevention 1994 Revised
classification system for human immunodeficiency virus infection in
children less than 13 years of age. MMWR. 1994; 43:1-10
16. Grubman S, Gross E, Lerner-Weiss N, Older children and
adolescents living with perinatally acquired human immunodeficiency
virus infection. Pediatrics. 1995; 95:657-663[Abstract]
17. Lipson M Disclosure of diagnosis to children with human
immunodeficiency virus or acquired immunodeficiency syndrome. J Dev
Behav Pediatr. 1994; 15:S61-S65[Medline]
18. Lipson M What do you say to a child with
AIDS? Hastings Cent Rep. 1993; 23:6-12[Medline]
19 Burr CK, Emery LJ. Speaking with children and families about
HIV infections. In: Pizzo PA, Wilfert CM, eds. Pediatric AIDS: The
Challenge of HIV Infection in Infants, Children and Adolescents. 2nd ed.
Baltimore, MD: Williams& Wilkins: 1994:923-935
20. Wiener L, Septimus A. Psychosocial support for child and family.
In: Pizzo PA, Wilfert CM, eds. Pediatric AIDS: The Challenge of HIV
Infection in Infants, Children and Adolescents. 2nd ed. Baltimore, MD:
Williams & Wilkins1994:809-828:
21. Lavin AT, Porter SM, Shaw DM, School health services in the age
of AIDS. J Sch Health. 1994; 64:27-31[Medline]
22. Palfrey JS, Fenton T, Lavin AT, School children with HIV
infection: a survey of the nation's largest school districts. J Sch
Health. 1994; 64:22-26[Medline]
TABLE 1
Demographic Characteristics of
HIV-Infected School-age Children in Massachusetts, 1993-1994
Transmission
Hemophilia/transfusion
15 (16%)
Perinatal
Mother injected drugs
40 (43%)
Mother's partner injected drugs
23 (25%)
Other perinatal risk
14 (15%)
Child's care giver
Biological parent
53 (58%)
Other relative
20 (22%)
Unrelated foster family
8 (9%)
Adoptive family
11 (12%)
School
Public
76
(83%)
Private
3 (3%)
Parochial
5 (5%)
Home-schooled
5 (5%)
Too sick to attend school
3 (3%)
Grade
Elementary (K-2)
39 (42%)
Elementary (3-5)
23 (25%)
Middle (6-8)
12 (13%)
High (9-12)
3 (3%)
College
1 (1%)
Other*
14 (15%)
* Includes home-schooled (5), too sick to attend
school (3), or in ungraded classrooms (6).